References
- Berx G, van Roy F (2009). Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol, 1, a003129.
- Cai J, Zhao XL, Liu AW, Nian H, Zhang SH (2011). Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns. Phytomedicine, 18, 366-73. https://doi.org/10.1016/j.phymed.2010.08.006
- Cavallaro U, Christofori G (2004). Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer, 4, 118-32. https://doi.org/10.1038/nrc1276
- Chen B, Mariano J, Tsai YC, et al (2006). The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site. Proc Natl Acad Sci USA, 103, 341-6. https://doi.org/10.1073/pnas.0506618103
- Chiu CG, St-Pierre P, Nabi IR, Wiseman SM (2008). Autocrine motility factor receptor: a clinical review. Expert Rev Anticancer Ther, 8, 207-17. https://doi.org/10.1586/14737140.8.2.207
- Das R, Mariano J, Tsai YC, et al (2009). Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78. Mol Cell, 34, 674-85. https://doi.org/10.1016/j.molcel.2009.05.010
- Fairbank M, St-Pierre P, Nabi IR (2009). The complex biology of autocrine motility factor/ phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase. Mol Biosyst, 5, 793-801. https://doi.org/10.1039/b820820b
- Fang S, Ferrone M, Yang C, et al (2001). The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulumProc. Proc Natl Acad Sci USA, 98, 14422-7. https://doi.org/10.1073/pnas.251401598
- Funasaka T, Haga A, Raz A, Nagase H (2001). Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility. Biochem Biophys Res Commun, 285, 118-28. https://doi.org/10.1006/bbrc.2001.5135
- Funasaka T, Haga A, Raz A, Nagase H (2002). Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells. Int J Cancer, 101, 217-23. https://doi.org/10.1002/ijc.10617
- Funasaka T, Hu H, Yanagawa T, Hogan V, Raz A (2007). Downregulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells. Cancer Res, 67, 4236-43. https://doi.org/10.1158/0008-5472.CAN-06-3935
- Graziosi L, Marino E, Cavazzoni E, Donini A (2013). Prognostic value of the seventh AJCC/UICC TNM classification of noncardia gastric cancer. World J Surg Oncol, 11, 103. https://doi.org/10.1186/1477-7819-11-103
- Haga A, Funasaka T, Niinaka Y, Raz A, Nagase H (2003). The autocrine motility factor signaling induces tumor apoptotic resistance which regulates apoptosome expression. Int J Cancer, 107, 707-14. https://doi.org/10.1002/ijc.11449
- Haga A, Niinaka Y, Raz A (2000). Phosphohexose isomerase/autocrine motility factor/neuroleukin/ maturation factor is a multifunctional phosphoprotein. Biochim Biophys Acta, 1480, 235-44. https://doi.org/10.1016/S0167-4838(00)00075-3
- Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-74. https://doi.org/10.1016/j.cell.2011.02.013
- Hlubek F, Brabletz T, Budczies J, et al. Heterogeneous expression of Wnt/beta-catenin target genes within colorectal cancer. Int J Cancer, 121, 1941-8.
- Iiizumi M, Liu W, Pai SK, Furuta E, Watabe K (2008). Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta, 1786, 87-104.
- Jemal A, Bray F, Center MM, et al (2011). Global Cancer Statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Joshi B, Li L, Nabi IR (2010). A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase. J Biol Chem, 285, 8830-9. https://doi.org/10.1074/jbc.M109.074344
- Kostova Z, Tsai YC, Weissman AM (2007). Ubiquitin ligases, critical mediators of endoplasmic reticulum-associated degradation. Semin Cell Dev Biol, 18, 770-79. https://doi.org/10.1016/j.semcdb.2007.09.002
- Li FX, Zhang RP, Liang H, et al (2013). Validity and necessity of sub-classification of N3 in the 7th UICC TNM stage of gastric cancer. Asian Pac J Cancer Prev, 14, 2091-5. https://doi.org/10.7314/APJCP.2013.14.3.2091
- Liang JS, Kim T, Fang S, et al (2003). Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells. J Biol Chem, 278, 23984-8. https://doi.org/10.1074/jbc.M302683200
- Liotta LA, Mandler R, Murano G, et al (1986). Tumor cell autocrine motility factor. Proc Natl Acad Sci USA, 83, 3302-6. https://doi.org/10.1073/pnas.83.10.3302
- Miranti CK (2009). Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis. Cell Signal, 21, 196-211. https://doi.org/10.1016/j.cellsig.2008.08.023
- Morito D, Hirao K, Oda Y, et al (2008). Gp78 cooperates with RMA1 in endoplasmic reticulum-associated degradation of CFTRDeltaF508. Mol Biol Cell, 19, 1328-36. https://doi.org/10.1091/mbc.E07-06-0601
- Murray D, Horgan G, Macmathuna P, Doran P (2008). NET1-mediated RhoA activation facilitates lysophosphatidic acidinduced cell migration and invasion in gastric cancer. Br J Cancer, 99, 1322-9. https://doi.org/10.1038/sj.bjc.6604688
- Nakatsukasa K, Brodsky JL (2008). The recognition and retrotranslocation of misfolded proteins from the endoplasmic reticulum. Traffic, 9, 861-70. https://doi.org/10.1111/j.1600-0854.2008.00729.x
- Niinaka Y, Paku S, Haga A, Watanabe H, Raz A (1998). Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells. Cancer Res, 58, 2667-74.
- Nussenbaum F, Herman IM (2010). Tumor angiogenesis: insights and innovations. J Oncol, 2010, 132641.
- Peng CW, Wang LW, Zeng WJ, Yang XJ, Li Y (2013). Evaluation of the staging systems for gastric cancer. J Surg Oncol, 108, 93-105. https://doi.org/10.1002/jso.23360
- Romagnolia A, Oliverio S, Evangelisti C, et al (2003). Neuroleukin inhibition sensitises neuronal cells to caspasedependent apoptosis. Biochem Biophys Res Commun, 302, 448-53. https://doi.org/10.1016/S0006-291X(03)00188-8
- Saito H, Fukumoto Y, Osaki T, et al (2008). Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol, 97, 132-5. https://doi.org/10.1002/jso.20929
- Shimizu K, Tani M, Watanabe H, et al (1999). The autocrine motility factor gene encodes a novel type of seven transmembrane protein. FEBS Lett, 456, 295-300. https://doi.org/10.1016/S0014-5793(99)00966-7
- Siegel R, Naishadham MA, Jemal A (2013). Cancer Statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
- Silletti S, Watanabe H, Hogan V, Nabi IR, Raz A (1991). Purification of B16-F1 melanoma autocrine motility factor and its receptor. Cancer Res, 51, 3507-11.
- Sjoblom T, Jones S, Wood LD, et al (2006). The consensus coding sequences of human breast and colorectal cancers. Science, 314, 268-74. https://doi.org/10.1126/science.1133427
- Song BL, Sever N, DeBose-Boyd RA (2005). Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase. Mol Cell, 19, 829-40. https://doi.org/10.1016/j.molcel.2005.08.009
- Sud R, Wells D, Talbot IC, Delhanty JD (2001). Genetic alterations in gastric cancers from British patients. Cancer Genet Cytogenet, 126, 111-9. https://doi.org/10.1016/S0165-4608(00)00397-6
- Tahara E (2000). Molecular aspects of invasion and metastasis of stomach cancer. Verh Dtsch Ges Pathol, 84, 43-9.
- Thiery JP, Acloque H, Huang RY, Nieto MA (2009). Epithelialmesenchymal transitions in development and disease. Cell, 139, 871-90. https://doi.org/10.1016/j.cell.2009.11.007
- Tsai YC, Mendoza A, Mariano JM, et al (2007). The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nat Med, 13, 1504-9. https://doi.org/10.1038/nm1686
- Tsutsumi S, Gupta SK, Hogan V, Collard JG, Raz A (2002). Activation of small GTPase Rho is required for autocrine motility factor signaling. Cancer Res, 62, 4484-90.
- Tsutsumi S, Yanagawa T, Shimura T, et al (2003). Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling. J Biol Chem, 278, 32165-72. https://doi.org/10.1074/jbc.M304537200
- Wallace TA, Prueitt RL, Yi M, et al (2008). Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res, 68, 927-36. https://doi.org/10.1158/0008-5472.CAN-07-2608
- Watanabe H, Carmi P, Hogan V, et al (1991). Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem, 266, 13442-8.
- Watanabe H, Takehama K, Date M, Shinozaki T, Raz A (1996). Tumor cell motility factor is the neuroleukin/ phosphohexose isomerase polypeptide. Cancer Res, 56, 2960-3.
- Wei D, Gong W, Kanai M, et al (2005). Drastic down-regulation of kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res, 65, 2746-54. https://doi.org/10.1158/0008-5472.CAN-04-3619
- World Health Organization (2008). The global burden of disease: 2004 update. Geneva: World Health Organization.
- Yilmaz M, Christofori G (2009). EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev, 28, 15-33. https://doi.org/10.1007/s10555-008-9169-0
-
Zha L, Zhang J, Tang W, et al (2013). HMGA2 elicits EMT by activating the Wnt/
$\beta$ -catenin pathway in gastric cancer. Dig Dis Sci, 58, 724-33. https://doi.org/10.1007/s10620-012-2399-6 -
Zhang N, Zhang J, Wang ZW, Zha L, Huang Z (2012). Altered expression of Kruppel-like factor 4 and
$\beta$ -catenin in human gastric cancer. Oncol Lett, 3, 1017-22. - Zhong X, Shen Y, Ballar P, et al (2004). AAA ATPase p97/ valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation. J Biol Chem, 279, 45676-84. https://doi.org/10.1074/jbc.M409034200
Cited by
- N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer vol.12, pp.2, 2015, https://doi.org/10.3892/mmr.2015.3687
- Inhibitory Effects of Dunning Rat Prostate Tumor Fluid on Proliferation of the Metastatic MAT-LyLu Cell Line vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.831
- Autocrine motility factor receptor promotes the proliferation of human acute monocytic leukemia THP-1 cells vol.36, pp.3, 2015, https://doi.org/10.3892/ijmm.2015.2267
- Overexpression of E3 ubiquitin ligase tripartite motif 32 correlates with a poor prognosis in patients with gastric cancer vol.13, pp.5, 2017, https://doi.org/10.3892/ol.2017.5806